United EcoEnergy Corp. (OTCBB: UEEC), a business development company (BDC), today announced that its wholly-owned portfolio subsidiary, Epic Wound Care, Inc., has retained Jennifer M. McCallum, Ph.D., Esq. of The McCallum Law Firm P.C. to represent Epic as patent, regulatory and international counsel.

"Dr. McCallum has many years of experience on both national and international matters in the fields of Intellectual Property, Licensing and Distribution Agreements, and FDA Approval Guidance. Dr. McCallum is a patent attorney with a Ph.D. in Biotechnology from Colorado State University and a J.D. from the University of Colorado. She has received numerous awards and accolades in her field, including a 2008 Congressional Medal of Distinction and an appointment by Governor Owens to the Biotechnology Council for the State of Colorado. In addition, Jennifer has received four appointments as the Vice-Chair of the American Bar Association's Committee on Bioethics, and she was one of seven attorneys sponsored in 2006 by the American Bar Association for an in-person en banc lifetime admission to the US Supreme Court. In 2009, she was named one of the Rising Stars in the US legal field by Super Lawyers. She has also been voted one of the 40 top business leaders under the age of 40, and named Outstanding Woman in Business by the Denver Business Journal in 2004. Her firm was also recently voted one of the top 25 woman-owned businesses in Colorado for the second year in a row. Additionally, Dr. McCallum is a highly sought after speaker providing rare insight into complex legal and scientific issues largely centering on pharmaceuticals and stem cell sciences.

Dr. McCallum stated that, "The Epic product represents a very important leap in wound care technology that is urgently needed to stop bleeding, promote clotting and otherwise create a protective barrier over the wound."

"We are delighted to have someone of Dr. McCallum's considerable expertise representing Epic," said Kelly T. Hickel, CEO, United EcoEnergy. Mr. Hickel went on to comment, "We are highly confident that Dr. McCallum will be a valuable asset as Epic works to open up potentially lucrative international markets for its products. Her international expertise, in conjunction with Epic's recently announced distribution agreement with Coreva Health Science, should give the company a considerable edge in obtaining new orders for its products."

Epic has developed a ground-breaking gauze product designed for the wound care market. The gauze can be used on any wound where bleeding is present. Upon contact with moisture, the gauze forms a gel-like substance that acts as a homeostatic agent to stop the bleeding quickly. Once bleeding has ceased and coagulation has occurred, the product can be rinsed away with saline solution or lukewarm water.

United EcoEnergy Corp is a publicly traded Business Development Company (OTCBB: UEEC) based in New York City. The company focuses on portfolio investments in closely-held and microcap public companies developing best-of-breed solutions to growing markets. The Company invests primarily in senior secured loans, mezzanine loans and equity in furtherance of its business plan.

The company has interests in three companies: SSC, Inc. (www.shelbysupercars.com), the developer of the Ultimate Aero super car; City 24/7 LLC (www.city24x7.com), which provides safety and consumer information utilizing undervalued existing public payphone infrastructure through a patented interactive media venue; and, Epic Wound Care Inc., (www.abcgauze.com), a wholly owned United EcoEnergy subsidiary which is the manufacturer of Hemostyp(TM), an innovative gauze product designed for use on any wound where bleeding is still present.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.